Pharmaxon
	Developer of neurology and neuro-oncology drugs. The company engages in the discovery and development of drugs for nervous system disorders in which cell mobility is modified. The company\'s activities are currently concentrated on the development of therapies for spinal cord injury, memory disorders and glioblastoma. The company spun out of the Development Biology Institute of Marseille Luminy.
	['', 'neuro-oncology drugs', ' ', 'nervous system disorders', ' ', 'neurological drugs', '']
Qs Semiconductor Australia
	Developer of disruptive non-volatile random access memory. The company offers a computer non-volatile memory of high density.
	['', 'random access memory', 'RAM', 'non-volatile memory', '']
Voyager Therapeutics
	Provider of gene therapies for diseases of the central nervous system. The company is a gene therapy company that develops treatments for fatal and debilitating diseases of the central nervous system.
	['', 'gene therapy', ' ', 'central nervous system', ' ', 'adreno virus', '']
Capsant Neurotechnologies
	Provider of a technology platform based on organotypic slice cultures. The company focuses on solving problems in the discovery of novel targets and drugs for central nervous system disorders such as stroke, trauma, epilepsy, Parkinson\'s and Alzheimer\'s.
	['', 'drug evaluation', ' ', 'organotypic slice culture', ' ', 'nervous system disorder', '']
Myelos Neurosciences
	Developer of therapeutics for neuropathic pain, peripheral neuropathy and neurodegenerative central nervous system disorders. The company provides peptide therapy to treat nervous system disorders and related degenerative diseases to treat pain syndromes and peripheral neuropathies.
	['', 'neuropathic pain', ' ', 'peripheral neuropathy', '']
Intracellular Therapies
	Developer of drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). The company develops compounds to treat neuropsychiatric and neurological diseases. It also develops a state of the art technology platform for generating a unique molecular signature for drug compounds.
	['', 'neuropsychiatric disease treatment', ' ', 'neurological disease treatment', ' ', 'drug compound', ' ', 'drug development', '']
Xytis
	Developer of central nervous system (CNS) drug candidates. The company is assembling a pipeline of innovative compounds with validated mechanisms of action, addressing major unmet clinical needs in CNS fields such as Schizophrenia, Traumatic Brain Injury, Depression, Anxiety, or Insomnia. It has two clinical stage compounds in development and operates from the USA, UK and Switzerland.
	['', 'central nervous system', ' ', 'nervous system disorder', ' ', 'cognition enhancement', ' ', 'schizophrenia treatment', '']
Sention
	Developer of drugs to treat memory impairment and other central nervous system disorders. The company develops lead compounds using its specialized genomics and behavioral models to treat other major central nervous system disorders.
	['memory ', 'nervous disorder', ' ', 'specialized genomics', ' ', 'behavioral model', ' nerve']
BRAINco Biopharma
	Developer of personalized treatments for nervous system diseases. The company develops new diagnostic tools and treatments against nervous system diseases optimizing individual drug treatment response, increasing remission rates and decreasing relapses rates.
	['', 'nervous system', ' ', 'antiepileptic treatment', ' diazepam phenitoin']
Ascendis Pharma
	Developer of pro-drug technology for endocrinology, cardiovascular and central nervous system disorders. The company develops a prodrug technology, TransCon, which conjugates the drug compound to a carrier molecule in a reversible fashion. It also provides transient conjugation technology, long-acting prodrugs of proteins, peptides and small molecules.
	['', 'drug-technology', ' ', 'conjugation technology', ' ', 'drug compound', ' ', 'carrier molecule', ' prodrug']
Axonia Medical
	Developer of tissue-engineered medical products for peripheral & central nervous system injury. The company produces living, functional tissue-engineered nerve grafts in the lab that can replace and repair damaged parts of the nervous system. It has developed technique for production of axons (instead of stem cells), the long thin parts of nerve cells that carry signals to distant target cells. Its regenerative treatments use neurons from patients or cadavers to grow long, integrated tracks of axons in the lab and then implants this tissue into the body, which then enables or accelerates the bodyâ€™s natural repair system.
	['', 'regenerative treatment', ' ', 'axon production', ' ', 'nervous tissue regeneration', ' ', 'nervous system injury', ' ', 'medical product', '']
